Education
About Us
Working with TipRanks
Follow Us
Bryant David Lim Insider Profile
4 Followers
Bryant David Lim, SVP & GC at Aceragen, holds 27.40K shares in Prelude Therapeutics (Ticker: PRLD), holds 309.69K shares in Aceragen (Ticker: ACGN). Most recently, Bryant David Lim Bought ― shares of Prelude Therapeutics on Dec 20, 2024 for an estimated value of $22.50K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
0.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bryant David Lim's holdings
Insider Roles
CLO, CFO, Corp Sec
Roles that Bryant David Lim holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 20, 2024 - Dec 20, 2025
Return:+64.60%
The most profitable trade made by Bryant David Lim
Bryant David Lim's Trading History
Aceragen
Jan 10, 2023
―
Uninformative Buy
―
$117.68K
Prelude Therapeutics
Dec 20, 2024
CLO, CFO, Corp Sec
Informative Buy
22.50K
$72.06K
List of latest transactions for each holding click on a transaction to see Bryant David Lim's performance on stock
You May Also Like
Bryant David Lim insider profile FAQ
What is the percentage of profitable transactions made by Bryant David Lim?
The percentage of profitable transactions made by Bryant David Lim is 33%.
What is the average return per transaction made by Bryant David Lim?
The average return per transaction made by Bryant David Lim is 0.00%.
What stocks does Bryant David Lim hold?
Bryant David Lim holds: ACGN, PRLD stocks.
What was Bryant David Lim’s latest transaction?
Bryant David Lim latest transaction was an Informative Buy of $22.50K.
What was Bryant David Lim's most profitable transaction?
Bryant David Lim’s most profitable transaction was an Informative Buy of PRLD stock on December 20, 2024. The return on the trade was 64.60%.
What is Bryant David Lim's role in Aceragen?
Bryant David Lim's role in Aceragen is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.